https://www.live-feeds.com/feed/scientists-test-first-ever-therapy-to-make-human-cells-young-againContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/scientists-test-first-ever-therapy-to-make-human-cells-young-againhttps://www.live-feeds.com/feed/scientists-test-first-ever-therapy-to-make-human-cells-young-again#u15961Sat, 27 Jun 2026 15:17:06 +0000Life Biosciences has administered the first gene therapy designed to treat optic neuropathies in a living patient. This procedure aims to reprogram old human cells to reverse cellular aging and treat incurable vision loss. Researchers warn that the process carries a risk of cancer.What's confirmed:Scientists are attempting to reverse cellular aging in a living patient to treat incurable vision loss.The first participant in a clinical trial to reverse human aging has been treated.Still unconfirmed:Life Biosciences conducted the world's first gene therapy for optic neuropathies on June 9.Th https://www.live-feeds.com/feed/scientists-test-first-ever-therapy-to-make-human-cells-young-againhttps://www.live-feeds.com/feed/scientists-test-first-ever-therapy-to-make-human-cells-young-again#u10653Wed, 24 Jun 2026 02:16:31 +0000Scientists have started the first human clinical trials for a gene therapy called ER-100. The treatment aims to rejuvenate aging cells to treat age-related eye diseases. Researchers have already treated the first participant in the study.What's confirmed:The first human trial of ER-100 gene therapy aims to reprogram aging cells to reverse age-related eye diseases.Researchers have treated the first participant in a clinical trial aimed at cellular reprogramming.Still unconfirmed:The therapy may be used specifically for glaucoma treatment.A US company is offering an unapproved gene therapy that